Efficacy and optimal dose of sildenafil in primary pulmonary hypertension

International Journal of Cardiology

Volumn 99, Issue 1, 2005, Pages 91-95

  Chockalingam, Anand ^a   Gnanavelu, G ^a   Venkatesan, S ^a   Elangovan, S ^a   Jagannathan, V ^a   Subramaniam, T ^a   Alagesan, R ^a   Dorairajan, Smrita ^a  

^a MADRAS MEDICAL COLLEGE   (India)

Author keywords

Management; Primary pulmonary hypertension; Pulmonary hypertension; Sildenafil

Indexed keywords

NIFEDIPINE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART SIZE; HUMAN; HYPOTENSION; LEG EDEMA; LUNG ARTERY PRESSURE; LUNG PARENCHYMA; MALE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYNCOPE; VASODILATATION;

EID: 13844317361     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.12.023     Document Type: Article

References (25)

1. Galie N., Manes A., Branzi A. Medical therapy of pulmonary hypertension. The prostacyclins. Clin. Chest. Med. 22:2001;529-537
2. Rich S., Kaufmann E., Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327:1992;76-81
3. Trulock E.P. Lung transplantation for primary pulmonary hypertension. Clin. Chest. Med. 22:2001;583-593
4. Galie N., Humbert M., Vichiery J.L., et al. Effect of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 39:2002;1496-1502
5. Nagaya N., Shimuzu Y., Satoh T., et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary thromboembolic pulmonary hypertension. Heart. 87:2002;340-345
6. Wilkens H., Guth A., Koenig J.B., et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation. 104:2001;1218-1222
7. Simmoneau G., Barst R.D., Galio N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double blind randomized controlled trial. Am. J. Respir. Crit. Care Med. 165:2002;800-804
8. Prasad S., Wilkinson J., Gatzoulis M.A. Sildenafil in primary pulmonary hypertension. N. Engl. J. Med. 343:2000;1342
9. Atz A.M., Wessel S.R. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology. 91:1999;307-310
10. Abrams D., Schulze-Neick I., Magee A.G. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart. 84:2000;E4
11. Ghofrani H.A., Weidmann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann. Intern. Med. 136:2002;515-522
12. Waternable H., Ohashi K., Takenchi K., et al. Sildenafil from primary and secondary pulmonary hypertension. Clin. Pharmacol. Ther. 71:2002;398-402
13. E Michelakis, W Tymchak, D Lien, et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide, Circulation 2002 21;105(20):2398-403.
14. Singh B., Gupta R., Punj V., et al. Sildenafil in the management of primary pulmonary hypertension. Indian Heart J. 54:2002;297-300
15. Sastry B.K., Narasimhan C., Reddy N.K., et al. A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J. 54:2002;410-414
16. Bharani A., Mathew V., Sahu A., Lunia B. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Indian Heart J. 55:2003;55-59
17. Kevin K.B., Helmersen D., Zygun D.A., Viner S.M. Sildenafil treatment of primary pulmonary hypertension. Can. Respir. J. 10:2003;48-50
18. Ghofrani H.A., Wiedemann R., Rose F., et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 360:2002;895-900
19. Molina J., Lucero E., Luluaga S., et al. Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy. Lupus. 12:2003;321-323
20. Laquay N., Levy M.L., Vaccaroni L., et al. Use of oral sildenafil (Viagra) in pulmonary hypertension after cardiac pediatric surgery. Ann. Fr. Anesth. Reanim. 22:2003;140-143
21. Ghofrani H.A., Schermuly R.T., Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am. J. Respir. Crit. Care Med. 167:2003;1139-1141
22. Borg G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 14:1982;377-381
23. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ. 132:1985;919-923
24. Sitbon O., Badesch D.B., Channick R.N., et al. Effects of the dual endothelin receptor antagonist Bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest. 124:2003;247-254
25. Kothari S.S., Duggal S. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart J. 54:2002;404-409